For companies
For universities
bcmas-product

Official board certification for medical science liaisons (MSLs) and medical affairs professionals

BCMAS Information

Full 360 view of the BCMAS

BCMAS Reviews

Recommended by thousands

BCMAS Price

Quick & easy payment options

Why Certify with BCMAS?

More reasons to certify with the BCMAS

BCMAS Quick Links

Certify Your Team with BCMAS
BCMAS Recertification
BCMAS Extension
BCMAS Scholarship
BCMAS Audio
See What Others are Saying About BCMAS
BCMAS FAQs
BCMAS Policies
BCMAS Impact Report
bcmas-product

Access whitepapers, eBooks, best practices, slide decks, and more all for free

Blogs

Premium medical affairs blogs

Webinars

Explore informative & trending webinars

Free Downloadables

Whitepapers, guides, ebooks and more

Events

Discover medical affairs events

Resources Quick Links

About Us
Definitive Guide for MSLs
Definitive Guide for Pharmacists
What is an MSL?
Why Medical Affairs?
Transforming Pharma
Social Responsibility
Free Program
Contact us

Connect with us

NORTH AMERICA

800 Kinderkamack Road Suite 206N Oradell, New Jersey 07649 USA

(855)-255-7137

info@acmainfo.org

Keep up with medical affairs trends

Sign up for our newsletter (no spam)

Board Certified medical affairs specialist program (BCMAS)

BCMAS info

BCMAS price

BCMAS reviews

Why certify with BCMAS?

BCMAS extensions

BCMAS recertification

BCMAS scholarships

BCMAS audio

BCMAS policies

BCMAS FAQs

BCMAS promote your certification

BCMAS exam information

Award winning certifications

Board Certified Medical Affairs Specialist (BCMAS)

Board Certified Biologics and Biosimilars Specialist (BCBBS)

Medical Affairs Competency Certificate (MACC)

Medical Device Industry

The Diagnostics Industry

The Fundamentals of Pharmaceutical Industry Compliance

Regulatory Affairs Expert Program (RAEP)

Accelerated Medical Science Liaison (AMSL®)

Pharmaceutical KOL Speaker Certificate

PhRMA Code Attestation

Resources

Product catalog

Blogs

Webinars

Free downlodables

Events

What is an MSL?

Why medical affairs?

Free program

News

Social responsibility

Scientific research

Company

About ACMA

Press center

Featured jobs — We're hiring

Board of governors

The Medical Affairs Leadership Council (MALC)

FAQs

ACMA Fellowship

ACMA Mentorship

Become a Mentor

Contact us — 24/7 support

ACMA life sciences

ACMA verify

TermsPrivacyAcademic IntegrityAnti DiscriminationConflict of InterestInstallments Policy
Copyright © 2026 Accreditation Council for Medical Affairs. All Rights Reserved.
    1. Home

    2. About ACMA

    Accreditation Council for Medical Affairs (ACMA)

    ACMA leads a transformative healthcare movement, partnering with 250+ pharmaceutical companies to pioneer higher standards in the life sciences.

    • About

    • ACMA In the News

    • Board of Governors

    • Medical Affairs Leadership Council

    • Events

    • Fellowship

    • Contact Us

    • About
    • ACMA In the News
    • Board of Governors
    • Medical Affairs Leadership Council
    • Events
    • Fellowship
    • Contact Us

    Partnering with the top 900+ pharma, biotech and healthcare organizations

    • cardinal
    • novartis
    • abbvie
    • gilead
    • gsk
    • novo+nordisk
    • pfizer
    • roche
    • sanofi
    • takeda
    • cardinal
    • novartis
    • abbvie
    • gilead
    • gsk
    • novo+nordisk
    • pfizer
    • roche
    • sanofi
    • takeda

    Establishing standards of excellence in the life sciences

    Accredited Certification

    Thousands of certified ACMA industry professionals from the top 250+ pharma/biotech companies and healthcare systems worldwide

    Global

    With users in over 80+ countries, the ACMA has developed customized certification & training programs with country & region specific content.

    Leadership

    The ACMA was invited by the US Congress Health sub-committee as a thought leader to discuss professional standards and has been the recipient of several prestigious awards in the life sciences.

    Research Driven

    Supported by evidence and research, ACMA educational programs make a significant difference.

    Who we are

    At ACMA, we're at the forefront of a transformative movement in healthcare. With over 250 pharmaceutical companies as our allies, we're redefining what it means to serve in the life sciences sector. We're not just participants; we're pioneers, committed to elevating the standards of medical affairs, market access, reimbursement and healthcare practices globally.

    Our mission

    To establish a higher level of global standards of excellence in partnership with pharmaceutical, biotech, medical device, diagnostic and healthcare fields through accredited training and technical solutions that improve patient outcomes and instill a higher level of integrity and excellence across the life sciences industry.

    We believe that the foundation of exceptional patient care is built on the expertise and ethical conduct of those who serve in the life sciences.

    Through our efforts, we're creating a culture of continuous improvement, where best practices in patient outcomes and healthcare provider interactions are not just goals, but guarantees.

    ACMA Founder/CEO, William Soliman, speaks about the ACMA's mission

    What sets us apart?

    What makes ACMA unique is our unwavering dedication to the betterment of healthcare through technology, education, accreditation, and advocacy.

    We champion the cause of elevating competencies within the pharmaceutical and healthcare sectors, ensuring that every professional's skills are not only up-to-date but also aligned with the highest ethical standards. Our commitment extends beyond the individual; it's about uplifting the entire ecosystem to ensure that patient care is always at the forefront.

    Our vision for the future

    We envision a world where trust in the life sciences industry is unshakeable, where every patient interaction is informed by the highest standards of knowledge and care. In this future, ACMA's role as a catalyst for change is recognized globally, as we continue to advocate for practices that prioritize patient well being above all else. We see a landscape where transparency, ethical practices, and cutting edge innovation converge to drive breakthrough therapies and improved health outcomes. Through collaborative partnerships and advanced technologies, we aim to enhance accessibility to life saving treatments worldwide, reduce healthcare disparities, and foster an environment of continuous learning and improvement across the industry.

    Join us

    Join the ACMA movement, now in 80+ countries, and be part of a community that values integrity, excellence, and the relentless pursuit of better healthcare for all. Together, we're not just changing standards; we're changing lives, one patient at a time. Let's build a future where excellence in healthcare is the norm, not the exception.

    Our Core Values

    We can change the world for the better by establishing standards of excellence

    We believe in doing what's right

    We believe in challenging the status quo

    What We Do

    Accredited Certification

    We offer the only accredited board certification for MSL & Medical Affairs professionals in the world. The BCMAS program is the industry's most respected credential.

    Certifications

    Life Sciences Market Research

    Uncover insights with ACMA Trends. An interactive Market Research Platform to help your company achieve better stakeholder engagement and stay competitive.

    Business solutions

    Transformative Consulting

    Whether you're looking for medication safety name testing, Medical Affairs KPI enhancement, or are focused on streamlining market access and field reimbursement, we can help your company achieve its goals.

    Consulting services

    A Commitment to Social Responsibility

    Scholarships

    Our scholarship program provides financial assistance to learners who could not otherwise continue their professional development.

    Scholarship information

    Advocacy

    The ACMA has been invited by the United States Congress Health Subcommittee to discuss the importance of professional standards for medical science liaison and medical affairs professionals.Listen to the Congressional Briefing here.

    Download a Free eBook for MSLs

    Diversity and Inclusion

    We're committed to actions and policies that ensure everyone at the ACMA, as well as our clients and partners, feels welcome and is treated with dignity and respect.

    More about diversity

    Our History

    2015

    Advisory Board

    The ACMA is founded and convenes an advisory board with healthcare thought leaders across the pharmaceutical, medicine, and academia industries. The board gained insights into the professional development needs of life sciences professionals with a particular focus on Medical Science Liaisons (MSLs) and Medical Affairs professionals.

    2016

    Accredited Certification

    The Board Certified Medical Affairs Specialist (BCMAS) programis launched and quickly becomes recognized as the certification standard of excellence for Medical Science Liaisons (MSLs) and Medical Affairs professionals. The ACMA becomes the first and only accredited organization offering board certification for Medical Affairs and MSLs.

    2017

    Global Growth

    Demand for the BCMAS program grows beyond the borders of the United States and the ACMA develops region- and country-specific content to address the global regulatory & compliance needs of the pharmaceutical industry. The ACMA launches the Pharmaceutical Representative Certification (PRC)program for localities in the U.S. which require pharmaceutical representative credentialing, such as Illinois and Washington D.C.

    2018

    Certificate Programs

    The ACMA launches several certificate programs such as the Regulatory Affairs Expert Program, Clinical Development Expert Program (CDEP), and more. The ACMA is featured in Forbes, Pharmaceutical Executive and ABC News for its work in raising the bar in the pharmaceutical industry.

    2019

    Certification Expansion

    The ACMA launches the Prior Authorization Certified Specialist (PACS) program and establishes the National Board of Prior Authorization Specialists. The ACMA also launches ACMA Society to help bring members of the life sciences community closer together.

    2020

    Technology

    The ACMA launches its technology solutions for the life sciences industry. The creation of ACMA Predict, a predictive analytics platform which offers sentiment analysis in the healthcare and pharma industries, paves the way for the ACMA's technological advances. The ACMA also receives the IACET/ANSI award as the Exemplar Training Organization of the Year in the Life Sciences.

    2021

    United States Congress

    The ACMA is invited by the U.S. Congress' House Committee on Energy and Commerce's Health Subcommittee to discuss Pharmaceutical Industry standards for Medical Science Liaison (MSL) and Medical Affairs professionals. Read more here.

    2022

    Leadership

    ACMA is considered a leader in the life sciences industry. ACMA leads a healthcare transformation, partnering with 250+ pharmaceutical companies. We elevate global standards in medical affairs, market access, reimbursement, and healthcare practices across the life sciences sector.

    2023

    ACMA Introduces AI

    ACMA introduces An AI enabled, cloud based, sophisticated machine learning tool that is trained on the largest compendium of data in the life sciences. It can be custom trained on your internal data (clinical studies, SOPs, articles, etc.). No more wasted time looking through shared drives and folders.